Mycetoma News and Research

RSS
WHO and Sanofi sign new agreement to sustain specific efforts to eliminate NTDs

WHO and Sanofi sign new agreement to sustain specific efforts to eliminate NTDs

COVID Moonshot receives key funding to accelerate drug discovery efforts

COVID Moonshot receives key funding to accelerate drug discovery efforts

Study: Neglecting development of therapeutics may repeat history and replicate vaccine inequality

Study: Neglecting development of therapeutics may repeat history and replicate vaccine inequality

ANTICOV clinical trial to test new treatment for people with mild-to-moderate COVID-19 in Africa

ANTICOV clinical trial to test new treatment for people with mild-to-moderate COVID-19 in Africa

World Malaria Day 2021: An interview with Sir Brian Greenwood

World Malaria Day 2021: An interview with Sir Brian Greenwood

World Health Organization, Sanofi sign new agreement to eliminate neglected tropical diseases

World Health Organization, Sanofi sign new agreement to eliminate neglected tropical diseases

Novartis and DNDi to partner on development of new oral treatment for visceral leishmaniasis

Novartis and DNDi to partner on development of new oral treatment for visceral leishmaniasis

International consortium to receive BRL 43.5 million for discovering drugs to treat neglected diseases

International consortium to receive BRL 43.5 million for discovering drugs to treat neglected diseases

'African eye worm' hampers efforts to eliminate river blindness, study shows

'African eye worm' hampers efforts to eliminate river blindness, study shows

People successfully treated for visceral leishmaniasis can still infect others, study confirms

People successfully treated for visceral leishmaniasis can still infect others, study confirms

Scientists study immune molecules inside mycetoma grains

Scientists study immune molecules inside mycetoma grains

Shorter treatment for Chagas disease found to be effective and safer than standard treatment

Shorter treatment for Chagas disease found to be effective and safer than standard treatment

New drug for sleeping sickness approved in the Democratic Republic of Congo

New drug for sleeping sickness approved in the Democratic Republic of Congo

Combination therapy shows high efficacy in treating people with leishmaniasis and HIV

Combination therapy shows high efficacy in treating people with leishmaniasis and HIV

EMA recommends first all-oral treatment to tackle deadly sleeping sickness

EMA recommends first all-oral treatment to tackle deadly sleeping sickness

Clinical trial begins to find better treatment for chronic cases of PKDL in Africa

Clinical trial begins to find better treatment for chronic cases of PKDL in Africa

Clinical study to find improved treatment for visceral leishmaniasis starts in eastern Africa

Clinical study to find improved treatment for visceral leishmaniasis starts in eastern Africa

Open Pharma drug discovery project aims to develop new treatments for mycetoma

Open Pharma drug discovery project aims to develop new treatments for mycetoma

GHIT Fund announces US$16.7 million to support development of new drugs, vaccines and diagnostics

GHIT Fund announces US$16.7 million to support development of new drugs, vaccines and diagnostics

First-ever clinical study for effective treatment of mycetoma begins in Sudan

First-ever clinical study for effective treatment of mycetoma begins in Sudan

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.